The U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray Spravato to treat adults with major depressive disorder (MDD), the company said on Tuesday. The approval paves the way for use of Spravato in patients whose disease has stopped… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on January 21, 2025
Many elderly people and their caregivers don’t know a doctor has diagnosed them with dementia. More than three-quarters of patients with dementia were not aware of their diagnosis, according to results recently published in the Journal of General Internal Medicine. It’s not… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]
Published on January 21, 2025
PASADENA, Calif. — As Fernando Ramirez drove to work the day after the Eaton Fire erupted, smoke darkened the sky, ash and embers rained onto his windshield, and the air smelled of melting rubber and plastic. He pulled to the side of the road and cried at the sight of residents trying to save their […]
Published on January 21, 2025